Sign In
Buy XPH
$66.82
-1.62 (-2.37%)
At Close: Jul 13, 2026
Which Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH?
03:28pm, Wednesday, 08'th Jul 2026
Invesco Nasdaq Biotechnology ETF offers a lower expense ratio and a higher trailing dividend yield than State Street SPDR S&P Pharmaceuticals ETF. State Street SPDR S&P Pharmaceuticals ETF has deliver
BBH vs. XPH: Which Healthcare ETF Is Better for Beginners?
07:28am, Wednesday, 08'th Jul 2026
State Street SPDR S&P Pharmaceuticals ETF provides exposure to 65 companies compared to the 25 holdings in VanEck Biotech ETF. VanEck Biotech ETF has experienced a deeper maximum drawdown of almost 40
3 Healthcare ETFs to Own in a Choppy Stock Market
02:04pm, Monday, 06'th Jul 2026
Healthcare stocks are attractive in a choppy market. These funds, focusing on the broader sector, drugmakers, and biotechs, are worth a look.
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
07:20am, Friday, 05'th Jun 2026
The State Street SPDR S&P Pharmaceuticals ETF (XPH) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio?
01:13pm, Thursday, 04'th Jun 2026
Explore how these two healthcare ETFs differ in diversification, sector focus, and portfolio concentration-key factors shaping their long-term investor appeal.
Biotech ETFs: Which ETF Offers Lower Fees? IBBQ or XPH?
11:16am, Thursday, 04'th Jun 2026
Compare diversification strategies and see how each ETF's unique index focus shapes risk and return for healthcare sector investors.
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
07:22am, Wednesday, 03'rd Jun 2026
Launched on June 19, 2006, the State Street SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of th
Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?
04:19pm, Tuesday, 19'th May 2026
The iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) is the rare fund that has spent the past year being publicly threatened by the President of the United States and quietly outperforming nearly every
Trump to announce discount drug pricing expansion, White House official says
12:47pm, Monday, 18'th May 2026
U.S. President Donald Trump will announce a dramatic expansion of TrumpRx.gov, a government-backed website offering discounted prescription drugs under his administration's pricing deal, on Mond
Could pressure to make money faster kill the next lifesaving pill?
11:27am, Wednesday, 15'th Apr 2026
When activist investors take a stake in a pharmaceutical company, markets often cheer. The expectation is leaner operations, sharper strategy and higher stock prices.
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
07:21am, Friday, 03'rd Apr 2026
The State Street SPDR S&P Pharmaceuticals ETF (XPH) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
07:22am, Monday, 30'th Mar 2026
The State Street SPDR S&P Pharmaceuticals ETF (XPH) was launched on June 19, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment o
US and China clash over fentanyl and tariffs at global drugs meeting
12:09pm, Monday, 09'th Mar 2026
The United States and China traded barbs at a U.N. drugs meeting on Monday, with Washington accusing Beijing of failing to stop sales of precursor chemicals for fentanyl and China dismissing the al
Short Interest in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Increases By 21.1%
02:14am, Friday, 06'th Mar 2026
SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH - Get Free Report) was the recipient of a large growth in short interest in February. As of February 13th, there was short interest totaling 781,872 shares,
These 5 Undervalued ETFs Could Be Bargains Right Now
07:55am, Thursday, 26'th Feb 2026
Not every exchange-traded fund (ETF) worth owning trades at a premium. Some of the most structurally sound funds sit quietly below the radar, offering low costs, reliable income, or sector exposure th
